论文部分内容阅读
目的观察孟鲁司特钠辅治小儿过敏性紫癜的临床疗效。方法将150例小儿过敏性紫癜随机分为研究组和对照组各75例。对照组患者采用临床常用的方法进行治疗,研究组患者采用孟鲁司特钠治疗,比较2组临床疗效。结果研究组总有效率为94.7%高于对照组的85.3%,差异有统计学意义(P<0.05)。结论孟鲁司特钠辅治小儿过敏性紫癜疗效较好,值得临床推广应用。
Objective To observe the clinical effect of montelukast on children with Henoch-Schonlein purpura. Methods 150 cases of children with Henoch-Schonlein purpura were randomly divided into study group and control group, 75 cases each. Patients in the control group were treated with commonly used methods. Patients in the study group were treated with montelukast sodium, and the clinical efficacy was compared between the two groups. Results The total effective rate was 94.7% in the study group and 85.3% in the control group, with significant difference (P <0.05). Conclusion Montelukast treatment of children with Henoch-Schonlein purpura is effective and worthy of clinical application.